We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;295(20):2327. doi:10.1001/jama.295.20.2327.
Text Size: A A A
Published online


Two articles in this issue address benefits associated with screening colonoscopy. Lin and colleaguesArticle analyzed cross-sectional data from individuals who had a screening colonoscopy to estimate the life-years saved when the screening examination detects colorectal cancer (CRC) in very elderly vs younger persons. Their analyses suggest that despite the higher prevalence of CRC in elderly individuals, screening colonoscopy among persons aged 80 years and older results in only 15% of the estimated gain in life expectancy experienced by persons aged 50 to 54 years. In another article, Singh and colleaguesArticle report results of a retrospective analysis of Manitoba Health claims and Manitoba Cancer Registry data, from which they assessed the magnitude and duration of CRC risk reduction after a negative colonoscopy. The authors' analyses suggest that persons with a negative colonoscopy examination have a 60% to 70% reduced risk of developing CRC compared with the general population, and this reduction in risk persists for more than 10 years. In an editorial, ChurchArticle discusses the contributions of these studies toward resolving several unanswered questions about the benefits of screening colonoscopy.


Magnetic resonance imaging (MRI) detects breast cancer earlier than mammography in women at high risk, but it is substantially more expensive. Plevritis and colleagues report results of a computer simulation to evaluate the cost-effectiveness of screening women with BRCA1 or BRCA2 mutations with mammography plus breast MRI vs mammography alone. The authors found that the cost-effectiveness of adding MRI to mammography varies by age. Based on a cost-effectiveness threshold of $100 000 per quality-adjusted life-year, the authors found that among women with BRCA1 mutations annual MRI plus mammography is cost-effective from ages 35 to 54 years and biannual MRI added to annual mammography is cost-effective for women aged 35 to 54 years with BRCA2 mutations.


The prevalence of overweight among adolescents in the United States has increased during the past 3 decades, but whether previously described socioeconomic disparities in overweight have increased, decreased, or held constant is not known. Miech and colleagues analyzed nationally representative data from 1971 to 2004 to examine trends in prevalence of adolescent overweight by family poverty status. The authors found that socioeconomic disparities in adolescent overweight widened from 1971 to 2004 among older adolescents aged 15 to 17 years but not among those aged 12 to 14 years.


Dr G is a 75-year-old semiretired surgeon who experienced an acute, unilateral loss of central vision approximately 3 years ago, which has progressed. Arroyo discusses the epidemiology, pathophysiology, diagnosis, and treatment of age-related macular degeneration.


“The electronic medical record (EMR) arrived at our teaching hospital one year ago and the resultant changes in medical student and physician notes have been remarkable.” From “Copy-and-Paste.”


Various studies suggest there is a link between inadequate amounts of sleep and obesity.


Potential for the Data Quality Act to silence or politicize objective scientific research and delay evidence-based public health policy.


Dr DeAngelis summarizes and comments on this week's issue. Go to http://jama.ama-assn.org/misc/audiocommentary.dtl.


For your patients: Information about age-related macular degeneration.



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...